(Date:7/24/2008)... MONROVIA, Calif., July 24 /PRNewswire-FirstC... leading developer, manufacturer and marketer of,m...nced that the Centers,for Medicare and Medicaid Se...heric cataract lenses as New Technology Intraocula...amer(R) Aspheric Single Piece foldable,intraocular...
(Date:7/24/2008)... Ground-breaking Technology Debuts in the Trance... Shoe, BOTHELL, Wash., July 24 /PRNewswi...Sports, Inc. today announced that BioMoGo, the wor... to consumers in the new Trance(TM),8 premium supp... times,faster than conventional athletic shoe mids...
(Date:7/24/2008)... NEW YORK, July 24 /PRNewswire/ -- MS -- Toda...nt things. For those who care for their,bodies, by...ations for,anti-aging, it is possible to feel and ...http://www.newscom.com/cgi-bin/prnh/20080724/NYFNS...uthor, and frequent guest on,Oprah Winfrey,s progr...
(Date:7/24/2008)... SCHAUMBURG, Ill., July 24 /PRNewswire/ -- A ...America,s most chronic problems -- obesity -- in,p... weight problem. About one third of us are,obese, ...ets -- they really,do look like us -- mirror us wi...esity, a public/private partnership that includes,...
Breaking Medicine News(10 mins):Health News:STAAR Surgical's Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification 2Health News:STAAR Surgical's Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification 3Health News:STAAR Surgical's Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification 4Health News:Brooks(R) Sports Launches BioMoGo Biodegradable Shoe 2Health News:Brooks(R) Sports Launches BioMoGo Biodegradable Shoe 3Health News:Live to 100 ... And Feel Great 2Health News:PetFit Challenge Helps Keep Pets - and Pet Owners - Healthy 2...o run the U.S. Food and Drug Administration, said ...ure while scientific decisions were being made//. ...ffectiveness of medical endeavors, the appropriate...ration. Dr. Andrew Eschenbach, acting administrat...
...uth Wales has conducted a study which revealed tha...the user's physical health// . It is one of the ...Cannabis abuse can lead to cardiovascular, respira.... It can decrease short-term memory and also slow...
... from the University of Michigan and Harvard Unive...o explore how different regions// of the brain are...f brands and products. The study, forthcoming in t...e first to use fMRI to assess consumer perceptions...
...D is important for bone development and may help p... particularly// colorectal cancer.To be effective ... needed and this can be dangerous and toxis. Now, ...di Comprehensive Cancer Center indicates that it m...
Other Medicine News:Health News:FDA Nominee Says That He Is Not Influenced By Politics 2Health News:Anticancer Properties of Vitamin D Revealed 2Health News:Anticancer Properties of Vitamin D Revealed 3(Date:7/23/2008)..., July 23 /- Sound Pharmaceuticals (S...ion with the FDA for the clinical,testing of a pro... of,chemotherapy induced hearing loss or ototoxici... will be tested in advanced stage lung cancer,and ...ased chemotherapy.,This marks the second developme...
(Date:7/23/2008)..., July 23 /- Dendreon Corpo...pects the Independent Data,Monitoring Committee (I...s,of overall survival relating to the Company,s Ph...inoma Treatment, also known as D9902B) clinical tr... Company,s investigational,active cellular immunot...
(Date:7/22/2008)...awards under Therapeutics Development Initiative b... to 23; next deadline January 20,2009, NEW YORK,... mission to,speed delivery of transformative treat...ael J. Fox Foundation for Parkinson,s Research has...stry research teams. The awards,were granted under...
(Date:7/22/2008)...frey Allan Will Stress the Importance to Patients ...Approval Pathway, RICHMOND, Va., July 22 /PRNewsw...developer of follow-on biologics and biopharmaceut... CEO of Insmed, will present at a,Congressional br...ignificant need for establishing an approval pathw...
Breaking Medicine Technology:Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 1Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 2Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 3Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 4Interferon does not slow or stop hepatitis C from worsening study finds 5962 1Interferon does not slow or stop hepatitis C from worsening study finds 5962 2UC San Diego Engineering Honor Society wins most outstanding chapter award 1161 1UC San Diego Engineering Honor Society wins most outstanding chapter award 1161 2Pill Poses Little Cervical Cancer Risk 5956 1Pill Poses Little Cervical Cancer Risk 5956 2Pill Poses Little Cervical Cancer Risk 5956 3...NEW YORK--(BUSINESS WIRE)--Apr 4, 2007 - ImClone S...rs Squibb Company (NYSE:,BMY) announced today that...imab) combined with platinum-based chemotherapy,me...val in patients,with recurrent and/or metastatic s...). The randomized, multi-center study, known as,EX...
...RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Apr...oday that following a,planned meeting of the indep...mpany,s ASSERT trial of senicapoc (formerly,ICA-17...dults, the,DMC recommended that the trial be termi...a reduction in crisis rate, the primary,endpoint. ...
Other Medicine Technology:Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 2Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 3Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 4Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 5Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 6Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 7Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 8Icagen Terminates Phase III ASSERT Study 2Icagen Terminates Phase III ASSERT Study 3Our Tri-Flo® suction catheter design was created to be less traumatic to your patients while still providing high suctioning efficiency. Our infant and pediatric catheters (5/6, 8 or 10 Fr) featu
Tracheal Suction Latex Rubber Catheters - Funnel End
Rubber bronchial coude catheter, X-ray opaque, one eye, whistle tip.
KCIs KinAir IV combines Advanced Pressure Relief Therapy with a manual wound care turn to provide optimum skin care and patient,positioning.
Medicine Products: